Prosecution Insights
Prosecution Insights
13 pending office actions • 10 art units • 12 examiners • 0 of 13 (0%) have an AI response strategy ready • 22 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 13 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 13 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (38%) |
| §102 only | 4 (31%) |
| §112 only | 2 (15%) |
| No statute on record | 2 (15%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZHANG, KAIJIANG | 2 | 76.5% | +35.3% |
| REDDIG, PETER J | 1 | 58.0% | +40.0% |
| WANG, RUIXUE | 1 | 57.6% | +23.2% |
| OUSPENSKI, ILIA I | 1 | 77.6% | +20.3% |
| KOVACH, KARA NICOLE | 1 | 100.0% | +0.0% |
| ROONEY, NORA MAUREEN | 1 | 60.5% | +23.2% |
| NGUYEN, QUANG | 1 | 38.2% | +52.8% |
| WHALEY, PABLO S | 1 | 25.2% | +21.2% |
| KOSTURKO, GEORGE W | 1 | 54.2% | +49.1% |
| YU, MISOOK | 1 | 38.5% | +15.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18340699 | INFERRING TRANSCRIPTION FACTOR ACTIVITY FROM DNA METHYLATION AND ITS APPLICATION AS A BIOMARKER | KOVACH, KARA NICOLE | 16d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18063532 | METHODS AND MATERIALS FOR CANINE BREED IDENTIFICATION | WHALEY, PABLO S | 7d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17631399 | METHODS AND COMPOSITIONS FOR INDUCING NOTCH SIGNALING IN TUMOR MICROENVIRONMENTS | YU, MISOOK | 73d overdue |
| 18458108 | EPSTEIN BARR VIRUS VACCINES | WANG, RUIXUE | 49d overdue |
| 18173485 | METHODS FOR ENHANCING ANTI-TUMOR ACTIVITY OF EXHAUSTED T CELLS | NGUYEN, QUANG | 2d overdue |
| 18500706 | COMBINATION THERAPIES FOR TREATMENT OF BCMA-RELATED CANCERS AND AUTOIMMUNE DISORDERS | REDDIG, PETER J | 5d |
| 18063532 | METHODS AND MATERIALS FOR CANINE BREED IDENTIFICATION | WHALEY, PABLO S | 7d |
| 18365110 | TARGETING OF PERI-NECROTIC TUMOR CELLS | OUSPENSKI, ILIA I | 21d |
| 17999240 | ANTI-FIBROTIC COMPOSITION AND RELATED METHODS | KOSTURKO, GEORGE W | 26d |
| 18310649 | KSHV ONCOPROTEIN ANTIGENS AND EPITOPES FOR EXPANDING ANTIGEN-SPECIFIC T CELLS | ROONEY, NORA MAUREEN | 42d |
| Art Unit | Apps |
|---|---|
| 1684 | 3 |
| 1641 | 2 |
| 1646 | 1 |
| 1672 | 1 |
| 1644 | 1 |
| 1681 | 1 |
| 1631 | 1 |
| 3619 | 1 |
| 1621 | 1 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18500706 | COMBINATION THERAPIES FOR TREATMENT OF BCMA-RELATED CANCERS AND AUTOIMMUNE DISORDERS | REDDIG, PETER J | 1646 | Other | Non-Final OA | 5d | Pending | Nov 02, 2023 |
| 18458108 | EPSTEIN BARR VIRUS VACCINES | WANG, RUIXUE | 1672 | §112 | Non-Final OA | 49d overdue | Pending | Aug 29, 2023 |
| 18365110 | TARGETING OF PERI-NECROTIC TUMOR CELLS | OUSPENSKI, ILIA I | 1644 | §103 | Non-Final OA | 21d | Pending | Aug 03, 2023 |
| 18340699 | INFERRING TRANSCRIPTION FACTOR ACTIVITY FROM DNA METHYLATION AND ITS APPLICATION AS A BIOMARKER | KOVACH, KARA NICOLE | 1681 | §103 | Non-Final OA | 16d overdue | Pending | Jun 23, 2023 |
| 18310649 | KSHV ONCOPROTEIN ANTIGENS AND EPITOPES FOR EXPANDING ANTIGEN-SPECIFIC T CELLS | ROONEY, NORA MAUREEN | 1641 | §102 | Non-Final OA | 42d | Pending | May 02, 2023 |
| 18173485 | METHODS FOR ENHANCING ANTI-TUMOR ACTIVITY OF EXHAUSTED T CELLS | NGUYEN, QUANG | 1631 | Other | Non-Final OA | 2d overdue | Pending | Feb 23, 2023 |
| 18063532 | METHODS AND MATERIALS FOR CANINE BREED IDENTIFICATION | WHALEY, PABLO S | 3619 | §112 | Final Rejection | 7d | Pending | Dec 08, 2022 |
| 17999240 | ANTI-FIBROTIC COMPOSITION AND RELATED METHODS | KOSTURKO, GEORGE W | 1621 | §103 | Final Rejection | 26d | Pending | Nov 18, 2022 |
| 17631399 | METHODS AND COMPOSITIONS FOR INDUCING NOTCH SIGNALING IN TUMOR MICROENVIRONMENTS | YU, MISOOK | 1641 | §102 | Final Rejection | 73d overdue | Pending | Jan 28, 2022 |
| 17435610 | PROTEIN RESIDUE MAPPING USING A COMBINATION OF DEEP MUTATIONAL SCANNING AND PHAGE DISPLAY HIGH THROUGHPUT SEQUENCING | LAFAVE, ELIZABETH ROSE | 1684 | §103 | Non-Final OA | 35d | Pending | Sep 01, 2021 |
| 17464341 | COMPOSITIONS AND METHODS FOR ACCURATELY IDENTIFYING MUTATIONS | ZHANG, KAIJIANG | 1684 | §102 | Non-Final OA | 65d | Pending | Sep 01, 2021 |
| 17412105 | COMPOSITIONS AND METHODS FOR ACCURATELY IDENTIFYING MUTATIONS | ZHANG, KAIJIANG | 1684 | §102 | Non-Final OA | 65d | Pending | Aug 25, 2021 |
| 17044779 | NANOPARTICLES FOR GENE EXPRESSION AND USES THEREOF | REGLAS, GILLIAN CHELSEA | 1632 | §103 | Non-Final OA | 46d overdue | Pending | Oct 01, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial